Addition of sildenafil in patients with pulmonary arterial hypertension with inadequate response to bosentan monotherapy

BACKGROUND: Pulmonary arterial hypertension (PAH) remains a progressive disease despite improvement when using one of three medication classes: prostanoids, endothelin receptor antagonists or phosphodiesterase-5 inhibitors. Combination therapy has been proposed for patients with unsatisfactory respo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Porhownik, Nancy R, Al-Sharif, Hassan, Bshouty, Zoheir
Formato: Artigo
Lenguaje:Inglês
Publicado: Pulsus Group Inc 2008
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2682165/
https://ncbi.nlm.nih.gov/pubmed/19107243
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares